“Mycofix® is the only product on the market to achieve EU authorization for its mycotoxin deactivation capacities. The fact that Mycofix® has 3 such authorizations highlights the extent to which it offers absolute protection for poultry, turkey and ducks”, stated Ursula Hofstetter, Director Competence Center Mycotoxins at BIOMIN.
The European Union regulations (EU) 2017/913 and (EU) 2017/930 followed a series of procedural steps affirming the safety and effectiveness of FUMzyme® and Biomin® BBSH 797 as substances for the reduction of the contamination of feed by mycotoxins (fumonisins and trichothecenes, respectively).
In April 2017, the EU Standing Committee on the Food Chain and Animal Health (SCFCAH) voted in favor of the authorization of two components of Mycofix® —FUMzyme® and Biomin® BBSH 797— as “substances for reduction of the contamination of feed by mycotoxins” for all avian species.
BIOMIN achieved EU authorization of bentonite (Mycofix® Secure), which binds aflatoxins, for all species in 2013 (EU 1060/2013).
The mycotoxin threat
“The industry is becoming increasingly aware of the dangers that mycotoxins pose to flocks in all geographies,” stated Ms Hofstetter, adding that “given the high-powered detection tools employed and unmatched scope covered, the BIOMIN Mycotoxin Survey program provides the industry with the most comprehensive information on the prevalence of mycotoxins and possible threats to animals.”
The subclinical effects of mycotoxins in avian species include decreased nutrient absorption, impaired growth or laying performance, compromised gut integrity, greater susceptibility to disease, decreased vaccine efficacy, etc.—all of which negatively impact profitability.
“The keys to robust mycotoxin risk management are detection through regular testing and effective mitigation,” said Ms Hofstetter.
Mycofix® employs three modes of action –biotransformation, adsorption and bioprotection– to deliver absolute protection against mycotoxins. Numerous feeding trials have demonstrated the ability of Mycofix® to degrade or immobilize mycotoxins in the gastrointestinal tract of birds.
“The newest generation of Mycofix® is the culmination of over three decades of scientific research and product development,” explained Ms Hofstetter. “By counteracting the harm that fungal metabolites can cause, Mycofix® delivers better performance and genuine return on investment,” she added.
Due to the molecular structure of fumonisins, adsorptive substances, or binders, are not suitable to deactivate fumonisins completely. FUMzyme® biotransforms fumonisins specifically and irreversibly into non-toxic metabolites, thus avoiding complications associated with fumonisins contamination.
In November 2016, the European Food Safety Authority (EFSA) published a positive Scientific Opinion on the safety and efficacy of FUMzyme® for the application in poultry feed, acknowledged the efficacy of FUMzyme® in degrading fumonisins to non-toxic compounds in the gastrointestinal tract of poultry, as demonstrated in numerous feeding trials.
Demonstrating the effectiveness of FUMzyme® involved evidence using the serum sphinganine/sphingosine ratio, a key biomarker that indicates fumonisin exposure in animals.
About Biomin® BBSH 797
Due to the molecular structure of trichothecenes, adsorptive substances, or binders, are not effective to counteract trichothecenes. Biomin® BBSH 797 is the first-ever EU authorized microorganism that biotransforms trichothecenes into harmless metabolites.
In January 2017, EFSA published a positive Scientific Opinion on the safety and efficacy of Biomin® BBSH 797 for the application in feed, acknowledged the efficacy of Biomin® BBSH 797 in degrading trichothecenes to non-toxic compounds in the gastrointestinal tract of birds, as demonstrated in numerous feeding trials.